Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 -0.268M
March 31, 2026 0.431M
December 31, 2025 10.19M
September 30, 2025 12.89M
June 30, 2025 4.104M
March 31, 2025 -2.60M
December 31, 2024 -9.045M
September 30, 2024 -0.536M
June 30, 2024 -2.615M
March 31, 2024 3.233M
December 31, 2023 6.04M
September 30, 2023 9.256M
June 30, 2023 4.68M
March 31, 2023 -0.723M
December 31, 2022 2.033M
September 30, 2022 -9.166M
June 30, 2022 -8.415M
Date Value
March 31, 2022 -10.49M
December 31, 2021 -7.98M
September 30, 2021 -6.835M
June 30, 2021 -8.979M
March 31, 2021 -11.46M
December 31, 2020 -22.40M
September 30, 2020 -19.80M
June 30, 2020 -17.95M
March 31, 2020 -19.94M
December 31, 2019 -19.87M
September 30, 2019 -17.07M
June 30, 2019 -16.16M
March 31, 2019 -13.60M
December 31, 2018 -8.381M
September 30, 2018 -7.626M
June 30, 2018 -7.607M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Aquestive Therapeutics, Inc. -45.95M
Pfizer Inc. 10.99B
Elite Pharmaceuticals, Inc. 17.53M
Daré Bioscience, Inc. -11.76M
Liquidia Corp. 150.69M